Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Soleno Therapeutics Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- 0 vs. Q3 2021
- Shares held
- 28.8M
- −529.1K (−1.8%) vs. Q3 2021
- Total value
- $11.8M
- −$15.3M (−56.4%) vs. Q3 2021
- New holders
- 5
- 6 more added
- Sold out
- 5
- 9 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 227 | $2.09B |
| Q4 2025 | 248 | $3.01B |
| Q3 2025 | 240 | $4.41B |
| Q2 2025 | 234 | $4.75B |
| Q1 2025 | 217 | $3.90B |
| Q4 2024 | 166 | $2.29B |
| Q3 2024 | 142 | $2.38B |
| Q2 2024 | 114 | $1.79B |
| Q1 2024 | 98 | $1.52B |
| Q4 2023 | 76 | $1.26B |
| Q3 2023 | 54 | $598.8M |
| Q2 2023 | 23 | $21.8M |
| Q1 2023 | 21 | $7.06M |
| Q4 2022 | 26 | $6.00M |
| Q3 2022 | 22 | $5.23M |
| Q2 2022 | 40 | $8.80M |
| Q1 2022 | 41 | $11.2M |
| Q4 2021 | 39 | $11.8M |
| Q3 2021 | 39 | $27.1M |
| Q2 2021 | 47 | $33.6M |
| Q1 2021 | 63 | $41.2M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Soleno Therapeutics Inc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cutler Group LP | 1,100 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 94 | $0 | 0.00% | −1−1.1% | Reduced |
| Wells Fargo & Company | 347 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 322 | $0 | 0.00% | −272−45.8% | Reduced |
| Royal Bank of Canada | 282 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 107 | $0 | 0.00% | +107 | New |
| Advisor Group Holdings, Inc. | 3,040 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bray Capital Advisors | 2,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,786 | $2.00K | 0.00% | +4,786 | New |
| Avantax Planning Partners, Inc. | 10,700 | $4.00K | 0.00% | 00.0% | Unchanged |
| Levy Wealth Management Group, LLC | 10,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Migdal Insurance & Financial Holdings Ltd. | 9,873 | $5.00K | 0.00% | −7,651−43.7% | Reduced |
| Boothbay Fund Management, LLC | 12,154 | $5.00K | 0.00% | 00.0% | Unchanged |
| Aspiriant, LLC | 17,295 | $7.00K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 19,920 | $8.00K | 0.00% | +19,920 | New |
| Virtu Financial LLC | 23,628 | $10.0K | 0.00% | +23,628 | New |
| UBS Group AG | 30,211 | $12.0K | 0.00% | +13,905+85.3% | Added |
| Bollard Group LLC | 34,322 | $14.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 42,270 | $17.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 43,941 | $18.0K | 0.00% | +30,911+237.2% | Added |
| Renaissance Technologies LLC | 60,600 | $25.0K | 0.00% | +50,200+482.7% | Added |
| Two Sigma Securities, LLC | 67,326 | $28.0K | 0.01% | +67,326 | New |
| Northern Trust Corp | 105,481 | $43.0K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 121,694 | $50.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 136,338 | $56.0K | 0.00% | +6,565+5.1% | Added |
| Susquehanna International Group, LLP | 136,743 | $56.0K | 0.00% | +30,850+29.1% | Added |
| BNP Paribas Arbitrage, SA | 140,189 | $57.5K | 0.00% | −157−0.1% | Reduced |
| Citadel Advisors LLC | 149,876 | $61.0K | 0.00% | −8,075−5.1% | Reduced |
| State Street Corp | 220,100 | $90.0K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 300,869 | $123.0K | 0.00% | −338,271−52.9% | Reduced |
| Two Sigma Investments, LP | 309,546 | $127.0K | 0.00% | −56,300−15.4% | Reduced |
| Two Sigma Advisers, LP | 398,000 | $163.0K | 0.00% | −346,000−46.5% | Reduced |
| Geode Capital Management, LLC | 430,253 | $176.0K | 0.00% | 00.0% | Unchanged |
| Granite Point Capital Management, L.P. | 846,850 | $347.0K | 0.14% | +145,012+20.7% | Added |
| Birchview Capital, LP | 876,899 | $360.0K | 0.23% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,064,392 | $846.0K | 0.00% | −4,120−0.2% | Reduced |
| Oracle Investment Management Inc | 2,132,000 | $874.0K | 0.13% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 9,765,129 | $4.00M | 0.25% | 00.0% | Unchanged |
| Abingworth LLP | 10,302,602 | $4.22M | 1.02% | 00.0% | Unchanged |
| Ergoteles LLC | 0 | $0 | 0.00% | −74,525−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −37,747−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −12,388−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −6,822−100.0% | Sold out |